Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 2Unknown 1

Sponsor Class

OTHER 3INDUSTRY 3

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Gynecologic 2Thoracic 1

Conditions

Endometrial Neoplasms 2Lung Neoplasms 1

Interventions

Cyclophosphamide 2042Radiotherapy 1859Cisplatin 1825Carboplatin 1533Gemcitabine 1434Paclitaxel 1289Bevacizumab 1270Docetaxel 1202pembrolizumab 1199Oxaliplatin 1160Capecitabine 1144Fluorouracil 1061Dexamethasone 971Rituximab 919Nivolumab 908Magnetic Resonance Spectroscopy 862Etoposide 839Doxorubicin 823Drug Therapy 792Radiosurgery 776Irinotecan 775Cytarabine 736fludarabine 716Leucovorin 676Lenalidomide 608fludarabine phosphate 564Temozolomide 552Radiation 541Filgrastim 540Cetuximab 537

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Interventional × Appointments and Schedules × Clear all
NCT06628167 2026-03-24

LCS II

Abramson Cancer Center at Penn Medicine

Phase NA Completed
252 enrolled 7 charts
Thoracic

Lung Neoplasms

NCT04763902 2023-11-30

TIMESPAN

University of Utah

Phase NA Completed
17 enrolled
Gynecologic

Endometrial Neoplasms

NCT04783467 2023-11-30

TREND

University of Utah

Phase NA Unknown
15 enrolled
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡